北大醫藥(000788.SZ):方正集團被申請重整
格隆匯2月18日丨北大醫藥(000788.SZ)公佈,2020年2月18日,公司收到北大方正集團有限公司(“方正集團”)的告知函,告知函稱,方正集團於近日收到北京市第一中級人民法院(“北京一中院”)送達的通知,北京銀行股份有限公司向北京一中院申請對方正集團進行重整。
截至公告日,債權人提出的重整申請是否被法院受理以及方正集團是否進入重整程序尚存在不確定性。
截至公告日,方正集團持有公司股東北大醫療產業集團有限公司(“北大醫療”)85.60%股權,北大醫療持有公司股份數量為7032.89萬股,佔公司股份總數的11.80%;北大醫療持有公司控股股東西南合成醫藥集團有限公司(“西南合成”)100%股權,西南合成持有公司股份數量為1.7億股,佔公司股份總數的28.58%。如果債權人對方正集團的重整申請被北京一中院受理,方正集團進入重整程序,將可能對公司股權結構等產生影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.